Reactive oxygen species generated by NADPH oxidase 2 and 4 are required for chondrogenic differentiation.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Kim KS;Kim KS; Choi HW; Yoon HE; Kim IY
  • Source:
    The Journal of biological chemistry [J Biol Chem] 2010 Dec 17; Vol. 285 (51), pp. 40294-302. Date of Electronic Publication: 2010 Oct 15.
  • Publication Type:
    Journal Article; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE
    • Publication Information:
      Publication: 2021- : [New York, NY] : Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology
      Original Publication: Baltimore, MD : American Society for Biochemistry and Molecular Biology
    • Subject Terms:
    • Abstract:
      Although generation of reactive oxygen species (ROS) by NADPH oxidases (Nox) is thought to be important for signal transduction in nonphagocytic cells, little is known of the role ROS plays in chondrogenesis. We therefore examined the possible contribution of ROS generation to chondrogenesis using both ATDC5 cells and primary chondrocytes derived from mouse embryos. The intracellular level of ROS was increased during the differentiation process, which was then blocked by treatment with the ROS scavenger N-acetylcysteine. Expression of Nox1 and Nox2 was increased upon differentiation of ATDC5 cells and primary mouse chondrocytes, whereas that of Nox4, which was relatively high initially, was decreased gradually during chondrogenesis. In developing limb, Nox1 and Nox2 were highly expressed in prehypertrophic and hypertrophic chondrocytes. However, Nox4 was highly expressed in proliferating chondrocytes and prehypertrophic chondrocytes. Depletion of Nox2 or Nox4 expression by RNA interference blocked both ROS generation and differentiation of ATDC5 cells, whereas depletion of Nox1 had no such effect. We also found that ATDC5 cells depleted of Nox2 or Nox4 underwent apoptosis. Further, inhibition of Akt phosphorylation along with subsequent activation of ERK was observed in the cells. Finally, depletion of Nox2 or Nox4 inhibited the accumulation of proteoglycan in primary chondrocytes. Taken together, our data suggest that ROS generated by Nox2 or Nox4 are essential for survival and differentiation in the early stage of chondrogenesis.
    • References:
      Dev Biol. 2003 Nov 15;263(2):165-75. (PMID: 14597193)
      Curr Opin Cell Biol. 2006 Dec;18(6):723-9. (PMID: 17049221)
      FEBS J. 2008 Jul;275(13):3249-77. (PMID: 18513324)
      Naunyn Schmiedebergs Arch Pharmacol. 2009 Aug;380(2):193-204. (PMID: 19337723)
      J Bone Miner Res. 2006 Jul;21(7):1003-11. (PMID: 16813521)
      Am J Physiol Cell Physiol. 2009 Apr;296(4):C711-23. (PMID: 19036941)
      Antioxid Redox Signal. 2009 Apr;11(4):747-64. (PMID: 18783311)
      J Biol Chem. 2001 Feb 23;276(8):5452-8. (PMID: 11098048)
      Free Radic Biol Med. 2007 Aug 1;43(3):319-31. (PMID: 17602947)
      J Biol Chem. 2003 Sep 19;278(38):36027-31. (PMID: 12840017)
      Antioxid Redox Signal. 2006 Sep-Oct;8(9-10):1485-96. (PMID: 16987005)
      J Cell Sci. 2001 Aug;114(Pt 16):2903-10. (PMID: 11686294)
      J Cell Biol. 1996 Apr;133(2):457-68. (PMID: 8609176)
      Bioessays. 1995 Dec;17(12):1039-48. (PMID: 8634065)
      Biochim Biophys Acta. 2007 Jul;1773(7):1015-27. (PMID: 17553579)
      Mol Cell Biol. 2004 Mar;24(5):1844-54. (PMID: 14966267)
      J Cell Biochem. 2010 Jun 1;110(3):573-80. (PMID: 20512918)
      Pediatr Nephrol. 2010 Apr;25(4):625-31. (PMID: 19949815)
      Arterioscler Thromb Vasc Biol. 2009 Feb;29(2):239-45. (PMID: 19057021)
      J Biol Chem. 2007 Aug 10;282(32):23500-8. (PMID: 17573353)
      J Exp Med. 2007 Jul 9;204(7):1613-23. (PMID: 17576777)
      J Immunol Methods. 1992 Nov 25;156(1):39-45. (PMID: 1431161)
      FEBS Lett. 2003 May 8;542(1-3):60-4. (PMID: 12729898)
      Osteoarthritis Cartilage. 2000 Sep;8(5):309-34. (PMID: 10966838)
      J Cell Biochem. 2006 Jan 1;97(1):33-44. (PMID: 16215986)
      Nature. 2003 May 15;423(6937):332-6. (PMID: 12748651)
      Cell Death Differ. 2008 May;15(5):867-78. (PMID: 18259192)
      Jpn J Infect Dis. 2004 Oct;57(5):S28-9. (PMID: 15507765)
      Dev Dyn. 2002 Oct;225(2):195-204. (PMID: 12242719)
      Curr Opin Cell Biol. 2001 Dec;13(6):721-7. (PMID: 11698188)
      Physiol Rev. 2007 Jan;87(1):245-313. (PMID: 17237347)
      Oncogene. 2006 Jun 22;25(26):3699-707. (PMID: 16532036)
      Biochem J. 2004 Feb 15;378(Pt 1):53-62. (PMID: 14594450)
      Gene. 2001 May 16;269(1-2):131-40. (PMID: 11376945)
      Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):42-8. (PMID: 17082491)
      Exp Cell Res. 2003 Nov 1;290(2):254-64. (PMID: 14567985)
      Mol Cell Biol. 2009 Aug;29(15):4201-19. (PMID: 19487464)
      J Med Invest. 2009 Feb;56(1-2):33-41. (PMID: 19262012)
      Antioxid Redox Signal. 2005 Jul-Aug;7(7-8):1021-31. (PMID: 15998257)
      Mol Cell Endocrinol. 2006 Apr 25;249(1-2):107-15. (PMID: 16530934)
      Arch Biochem Biophys. 2002 Jan 15;397(2):342-4. (PMID: 11795892)
      J Biol Chem. 2001 Nov 2;276(44):41229-36. (PMID: 11514554)
      Endocrinology. 2003 Oct;144(10):4659-68. (PMID: 12960068)
      Int J Cancer. 2008 Aug 15;123(4):787-92. (PMID: 18508317)
      Cell Differ Dev. 1990 May;30(2):109-16. (PMID: 2201423)
      Exp Cell Res. 2004 Dec 10;301(2):119-27. (PMID: 15530848)
      Nat Rev Immunol. 2004 Mar;4(3):181-9. (PMID: 15039755)
      J Biol Chem. 2009 Nov 13;284(46):31972-81. (PMID: 19762915)
    • Accession Number:
      0 (Free Radical Scavengers)
      0 (Membrane Glycoproteins)
      0 (Proteoglycans)
      0 (Reactive Oxygen Species)
      EC 1.6.3.- (Cybb protein, mouse)
      EC 1.6.3.- (NADPH Oxidase 2)
      EC 1.6.3.- (NADPH Oxidase 4)
      EC 1.6.3.- (NADPH Oxidases)
      EC 1.6.3.- (Nox4 protein, mouse)
      EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases)
      WYQ7N0BPYC (Acetylcysteine)
    • Publication Date:
      Date Created: 20101019 Date Completed: 20110111 Latest Revision: 20220317
    • Publication Date:
      20231215
    • Accession Number:
      PMC3001009
    • Accession Number:
      10.1074/jbc.M110.126821
    • Accession Number:
      20952384